OTC · ANTCF
Aion Therapeutic Inc.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
Loading market information…
OTC · SHMN · USD
Stock price
Quote as of Oct 29, 2026, 05:55 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
SOHM, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
$0.07-$0.01 (-13.71%)
Panacea Life Sciences Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.82% below the high.
$0.00$0.00 (0.0%)
EVIO, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Kaya Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.57% below the high.
$0.00$0.00 (0.0%)
Hemp, Inc’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Resonate Blends, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.6% below the high.
$0.00+$0.00 (+200.0%)
One World Products, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.18% below the high.
$0.00$0.00 (0.0%)
Bhang Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
